Mens rea proof may be key to Daiichi legal action against Singh bros amid war of words
This article was originally published in Scrip
Executive Summary
Was it alleged deception, connivance of the top brass, mens rea or then perhaps sheer lax due diligence that did for Japan's Daiichi Sankyo when it acquired Ranbaxy Laboratories in 2008 even as US regulators were deep-probing the company for violations concerning data integrity and GMP issues?